Grandview Asset Management LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,038 shares of the healthcare conglomerate's stock, valued at approximately $324,000.
Several other hedge funds have also recently added to or reduced their stakes in the business. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares in the last quarter. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the 1st quarter valued at about $42,000. O Brien Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after purchasing an additional 37 shares during the period. Finally, Kentucky Trust Co grew its holdings in UnitedHealth Group by 138.5% during the 1st quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate's stock worth $49,000 after acquiring an additional 54 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
UNH has been the topic of a number of recent analyst reports. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Truist Financial upped their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research note on Tuesday, September 9th. Barclays upped their target price on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Finally, Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research report on Friday, September 12th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.
Check Out Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $344.15 on Friday. The company has a 50 day moving average of $301.20 and a 200 day moving average of $359.58. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $311.69 billion, a P/E ratio of 14.91, a P/E/G ratio of 2.24 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's payout ratio is 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.